Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine and 5-HT3 with or without dexamethasone for CINV
NCT05805800Phase 3Completed
- Start
- Apr 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV). Started Apr 2023; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT05805800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05805800.